OncologyMetastatic Bone Disease

Pathological Fracture - Unknown Primary

Oncology
Intermediate
6 min
High Yield
pathological fracturebone metastasiscarcinoma of unknown primarylung cancerrenal cell carcinomaMirels score
6:00
Start the timer to simulate exam conditions

CIM Case: Pathological Fracture - Unknown Primary

Clinical Scenario

Patient: 68-year-old man Presentation: Sudden onset left thigh pain after standing from chair, unable to weight-bear, preceded by 6-week history of dull aching left thigh pain Relevant history: 40 pack-year smoking history (stopped 5 years ago), 8kg weight loss over 3 months, decreased appetite, productive cough for 2 months, no prior malignancy diagnosed, retired carpenter (asbestos exposure) Examination findings:

  • Cachectic appearance
  • Left leg shortened and externally rotated
  • Obvious deformity at mid-thigh level
  • Palpable mass around fracture site
  • Exquisitely tender at fracture site
  • Unable to perform SLR
  • Neurovascularly intact distally
  • Finger clubbing noted
  • Scattered rhonchi on chest auscultation
  • No palpable lymphadenopathy

Investigations Provided

Laboratory Results

TestResultNormal RangeInterpretation
Hb98 g/L130-170 g/L↓ Anaemia of chronic disease
WCC11.2 ×10⁹/L4-11 ×10⁹/L↑ Mildly elevated
Platelets425 ×10⁹/L150-400 ×10⁹/L↑ Reactive
CRP85 mg/L<5 mg/L↑ Elevated
ESR95 mm/hr<20 mm/hr↑ Markedly elevated
Calcium2.85 mmol/L2.2-2.6 mmol/L↑ Hypercalcaemia
ALP320 U/L30-120 U/L↑ Elevated (bone/liver)
Albumin28 g/L35-50 g/L↓ Hypoalbuminaemia
Creatinine125 μmol/L60-110 μmol/L↑ Mild renal impairment
PSA2.5 ng/mL<4 ng/mLNormal
Protein electrophoresisNo paraprotein-Excludes myeloma

Imaging

Image 1: AP and Lateral Radiographs of Left Femur

Radiological features:

  • Transverse fracture through mid-diaphysis of left femur
  • Large lytic lesion at fracture site (5cm)
  • Cortical destruction >75%
  • Moth-eaten/permeative margins
  • No matrix mineralisation (not bone-forming)
  • Pathological fracture through tumour
  • No periosteal reaction

Image 2: CT Chest/Abdomen/Pelvis

Findings:

  • 4.5cm spiculated mass in right upper lobe (highly suspicious for primary lung carcinoma)
  • Ipsilateral hilar lymphadenopathy
  • Multiple small pulmonary nodules bilaterally
  • Lytic lesion in L3 vertebral body
  • No liver metastases
  • No renal mass
  • No adrenal masses

Questions & Model Answers

Q

What is your differential diagnosis and most likely diagnosis?

Q

Describe your workup for carcinoma of unknown primary (CUP).

Q

How would you assess the risk of pathological fracture using Mirels score?

Q

How would you manage this pathological fracture?

Q

What is the prognosis and how does this affect your surgical decision-making?

Q

What if this patient had a solitary renal metastasis instead?


Key Teaching Points

Pattern Recognition

This pattern suggests Metastatic Carcinoma:

  • Adult >40 years with destructive bone lesion
  • Constitutional symptoms (weight loss, fatigue)
  • Lytic lesion without matrix production
  • Risk factors for primary malignancy (smoking)
  • Hypercalcaemia

Common Lytic Metastases (Mnemonic: "Kidney-Thyroid-Lung-Breast-Lick-Bone"):

  • Kidney (renal cell)
  • Thyroid
  • Lung
  • Breast

Common Blastic Metastases:

  • Prostate (most common)
  • Breast (can be mixed)
  • Carcinoid
  • Medulloblastoma

Critical Management Points

  1. Stabilise fracture first - don't delay for exhaustive workup
  2. Tissue diagnosis from fracture site - confirms primary
  3. Long nail for femoral shaft - protects entire bone
  4. Mirels score for impending fractures - ≥9 needs prophylactic fixation
  5. Adjuvant radiotherapy - improves local control
  6. MDT discussion - oncology, palliative care, radiation oncology
  7. Quality of life focus - palliative intent in most cases

Common Examiner Follow-ups

Q: "What are the most common sites for bone metastases?"

Most common sites (in order):

  1. Spine (thoracic > lumbar > cervical)
  2. Pelvis
  3. Proximal femur
  4. Ribs
  5. Proximal humerus
  6. Skull

Metastases occur in red marrow areas due to rich blood supply and Batson's venous plexus.


Q: "When would you consider curative resection for bone metastases?"

Curative resection may be considered when:

  • Solitary skeletal metastasis confirmed on staging
  • Primary controlled or controllable (nephrectomy for RCC)
  • Long disease-free interval (>2 years)
  • Favourable histology (RCC, thyroid, breast)
  • Patient fit for major surgery
  • Acceptable limb function expected post-resection

Most common scenario: solitary renal cell carcinoma metastasis


Q: "What is the role of radiotherapy in bone metastases?"

IndicationDosePurpose
Palliation (pain)8 Gy single fractionQuick pain relief
Post-operative30 Gy in 10 fractionsLocal control
Spinal cord compression20-30 GyDecompression if non-surgical
Impending fracture (low Mirels)30 GyPrevent fracture

Most bone metastases are radiosensitive except renal cell and melanoma.


Q: "How do you differentiate a pathological fracture from a traumatic fracture in the elderly?"

FeaturePathologicalTraumatic
MechanismMinimal traumaSignificant trauma
Prodromal painCommon (weeks)Absent
X-rayLytic lesion, cortical destructionNormal bone prior to fracture
Constitutional symptomsWeight loss, fatigueAbsent
Risk factorsMalignancy history, smokingFalls risk, osteoporosis

Any fracture with minimal trauma or visible lesion on X-ray should be considered pathological until proven otherwise.


  • Mirels Scoring System
  • Bone Metastasis Management
  • Intramedullary Nailing for Pathological Fractures
  • Renal Cell Carcinoma Metastases
  • Preoperative Embolisation
  • Palliative Orthopaedics